Clinical Trial Update: Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease [EARLY_Phase 1]

View source ↗

Summary

A pilot early-phase study evaluating inhaled nitric oxide for pulmonary insufficiency in congenital heart disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Insufficiency

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Pulmonary Insufficiency | EARLY_Phase 1 | Status: TERMINATED